Daiji Kawanami

3.7k total citations
81 papers, 2.7k citations indexed

About

Daiji Kawanami is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Daiji Kawanami has authored 81 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 31 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Nephrology. Recurrent topics in Daiji Kawanami's work include Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (17 papers) and Parathyroid Disorders and Treatments (10 papers). Daiji Kawanami is often cited by papers focused on Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (17 papers) and Parathyroid Disorders and Treatments (10 papers). Daiji Kawanami collaborates with scholars based in Japan, United States and Australia. Daiji Kawanami's co-authors include Kazunori Utsunomiya, Keiichiro Matoba, Yuichi Takashi, Koji Maemura, Tamotsu Yokota, Takefumi Nojiri, Norihiko Takeda, Ryozo Nagai, Yasushi Imai and Tomohiro Harada and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Immunity.

In The Last Decade

Daiji Kawanami

76 papers receiving 2.6k citations

Peers

Daiji Kawanami
Jee‐Young Han South Korea
Daiji Kawanami
Citations per year, relative to Daiji Kawanami Daiji Kawanami (= 1×) peers Jee‐Young Han

Countries citing papers authored by Daiji Kawanami

Since Specialization
Citations

This map shows the geographic impact of Daiji Kawanami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiji Kawanami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiji Kawanami more than expected).

Fields of papers citing papers by Daiji Kawanami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiji Kawanami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiji Kawanami. The network helps show where Daiji Kawanami may publish in the future.

Co-authorship network of co-authors of Daiji Kawanami

This figure shows the co-authorship network connecting the top 25 collaborators of Daiji Kawanami. A scholar is included among the top collaborators of Daiji Kawanami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiji Kawanami. Daiji Kawanami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Kazuo, Kei Takeshita, Takuya Hashimoto, et al.. (2025). Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study). Journal of Diabetes Investigation. 16(7). 1243–1253. 1 indexed citations
2.
Matsumura, Takeshi, Hiroyuki Takahashi, Takahisa Deguchi, et al.. (2025). Fingertip skin autofluorescence as a non‐invasive marker for vascular complications in patients with type 2 diabetes. Journal of Diabetes Investigation. 16(12). 2201–2212.
3.
Takashi, Yuichi, T. Sakamoto, Koji Teshima, et al.. (2025). Association between self-stigma and diabetic complications in Japanese people with type 2 diabetes: a cross-sectional study. BMJ Open. 15(6). e095698–e095698.
4.
Matoba, Keiichiro, Yosuke Nagai, Shinji Ohashi, et al.. (2024). Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis. Communications Biology. 7(1). 402–402. 3 indexed citations
5.
Matoba, Keiichiro, Yosuke Nagai, Shoji Nagao, et al.. (2024). Rho-associated, coiled-coil-containing protein kinase 2 regulates expression of mineralocorticoid receptor to mediate sodium reabsorption in mice. Biochemical and Biophysical Research Communications. 736. 150874–150874. 1 indexed citations
6.
Funakoshi, Shunsuke, Masayoshi Tsuji, Makiko Abe, et al.. (2023). Association between serum ALT levels and incidence of new-onset diabetes in general population of Japanese: a longitudinal observational study (ISSA-CKD). BMJ Open. 13(8). e074007–e074007. 6 indexed citations
7.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2022). ROCK2-induced metabolic rewiring in diabetic podocytopathy. Communications Biology. 5(1). 341–341. 11 indexed citations
8.
Takashi, Yuichi, Shun Sawatsubashi, Itsuro Endo, et al.. (2021). Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span. Biochemistry and Biophysics Reports. 27. 101107–101107. 17 indexed citations
9.
Kawanami, Daiji, et al.. (2021). Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Frontiers in Pharmacology. 12. 754239–754239. 28 indexed citations
10.
Yamashita, Shin-ichi, Takashi Nomiyama, Takako Kawanami, et al.. (2021). Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro. Diabetology International. 12(4). 389–398. 32 indexed citations
11.
Horikawa, Tsuyoshi, Takako Kawanami, Yuriko Hamaguchi, et al.. (2020). Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet. Heliyon. 6(11). e05431–e05431. 10 indexed citations
12.
Takaku, Shizuka, Hideji Yako, Naoko Niimi, et al.. (2018). Establishment of a myelinating co-culture system with a motor neuron-like cell line NSC-34 and an adult rat Schwann cell line IFRS1. Histochemistry and Cell Biology. 149(5). 537–543. 15 indexed citations
13.
Ishizawa, Sho, Junko Takahashi‐Fujigasaki, Yasushi Kanazawa, et al.. (2014). Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clinical and Experimental Nephrology. 18(6). 844–852. 34 indexed citations
14.
Matoba, Keiichiro, Daiji Kawanami, Rina Okada, et al.. (2013). Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney International. 84(3). 545–554. 80 indexed citations
15.
Kawanami, Daiji, et al.. (2012). Successful control of a case of severe insulin allergy with liraglutide. Journal of Diabetes Investigation. 4(1). 94–96. 10 indexed citations
16.
Mahabeleshwar, Ganapati H., Daiji Kawanami, Nikunj Sharma, et al.. (2011). The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock. Immunity. 35(1). 146–146. 4 indexed citations
17.
Mahabeleshwar, Ganapati H., Daiji Kawanami, Nikunj Sharma, et al.. (2011). The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock. Immunity. 34(5). 715–728. 111 indexed citations
18.
Shiga, Taro, Koji Maemura, Yasushi Imai, et al.. (2007). Abstract 1725: Long Pentraxin3 (PTX3) is More Specific than CRP as a Marker for Vascular Inflammation. Circulation. 116. 1 indexed citations
19.
Kawanami, Daiji, Koji Maemura, Norihiko Takeda, et al.. (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine–endothelial cell interactions. Biochemical and Biophysical Research Communications. 314(2). 415–419. 388 indexed citations
20.
Kawanami, Daiji, Koji Maemura, Norihiko Takeda, et al.. (2003). Direct Proatherogenic Effect of C-Reactive Protein on Vascular Endothelial Cells. Japanese Circulation Journal-english Edition. 67. 139–140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026